Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders

2020/02/05 by Jessica A. Kaczorowski, Taylor F. Smith, Amanda M. Shrewsbury +4 · 8 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Neurofibromatosis and Schwannoma Cases #Genetics and Neurodevelopmental Disorders #Chromatin Remodeling and Cancer

paper · doi:10.1007/s10519-020-09991-x

Citations

• Validity of the Executive Function Theory of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review

Cited by

• Roles of palmitoylation in structural long-term synaptic plasticity. [europepmc]
• Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1. [europepmc]
• Early Developmental Signs in Children with Autism Spectrum Disorder: Results from the Japan Environment and Children's Study. [europepmc]
• Allostery, and how to define and measure signal transduction. [europepmc]
• Steady-state visual evoked potentials in children with neurofibromatosis type 1: associations with behavioral rating scales and impact of psychostimulant medication. [europepmc]
• A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD). [europepmc]
• Clinical and epidemiological characterisation of neurofibromatosis type 1: Combined analysis of a reference hospital in Brazil and DataSUS. [europepmc]
• Zebrafish neurofibromatosis type 1 mutants show disruption of sleep but not of circadian rhythms. [europepmc]